Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02849704 · ClinicalTrials.gov registry record · Phase 2
Fat Malabsorption in Chronic Pancreatitis
A Phase 2 study, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- Phase 2
- Development phase
- 48
- Enrollment target
NCT02849704 is a Phase 2 study that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 48 participants.
The verdict
NCT02849704, a Phase 2 study, has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 48 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the malabsorption blood test (MBT), stool coefficient of fat absorption (CFA) and stool bomb calorimetry (BC) methods as potential screening or diagnostic tests for reduced exocrine pancreatic function or pancreatic insufficiency (RPF/PI). A further objective is to determine the test responses before and after pancreatic enzyme medication administration (Creon36™) in the patients with chronic pancreatitis (CP).
Interventions
- DRUG Creon36™
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2016-10-13 |
| Est. Completion | 2017-11-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02849704
The ClinicalTrials.gov registry entry for NCT02849704 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Creon36™ is the first listed.
NCT02849704 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02849704 about?
NCT02849704 is a clinical study titled "Fat Malabsorption in Chronic Pancreatitis". The objective of this study is to evaluate the malabsorption blood test (MBT), stool coefficient of fat absorption (CFA) and stool bomb calorimetry (BC) methods as potential screening or diagnostic tests for reduced exocrine pancreatic function or pancreatic insufficiency (RPF/PI). A further objecti...
What is the current status of trial NCT02849704?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 48 participants. The study started on 2016-10-13. Estimated completion is 2017-11-01.
What interventions are being tested in trial NCT02849704?
The interventions under investigation include: Creon36™ (DRUG).
Who is sponsoring clinical trial NCT02849704?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.